Lyphe Group launches Australian medical cannabis clinic

Lyphe Group, the company behind one of the UK’s major medical cannabis clinics, has opened its doors down under.

Lyphe Group, the parent company behind The Medical Cannabis Clinics, which prescribes to thousands of patients in the UK, has announced its expansion into Australia.

The Lyphe Clinic, which launched online in Australia earlier this month, with a team of experienced medical cannabis clinicians on board, reportedly has over 500 patients who have signed up to receive prescription cannabis. 

Medical cannabis was legalised by the Australian Government in 2016, with the country’s Therapeutic Goods Administration regulating its use. 

Over 100 different medicinal cannabis products are currently available in Australia via prescriptions from a doctor or specialist. 

Patients are seen virtually via Telehealth, allowing for informative and affordable consultations in the comfort of their own home. 

It also means patients, who are often suffering from chronic illnesses, can be seen from across the country, meaning patients in more rural regions will not miss out. 

The team also plans to partner with pharmacies in the cannabis field to make sure patients can seamlessly and effectively access their medication, at an affordable cost. 

The team at Lyphe Clinic is made up of medical cannabis experts who have been in the field since the medication was legalised.

Clinical director, Georgie Lutz, has five years experience in the medical cannabis industry and has expertise in launching and running successful alternative medical cannabis clinics. 

Dr Hermanus Bosman has been working in the field of alternative medicine since 2019 and also currently works in general practice. His work in the field and strong reputation has earned him a large patient following. 

The team is completed by Nicholas Robinson, registered nurse and clinic coordinator. 

Nick has been working in the alternative medicine space for the last two years and shares his team’s passion for helping patients on their medicinal cannabis journey. 

READ MORE: Cannabis down under: ‘Record numbers’ of doctors prescribing as access hits all-time high

Lutz commented: “The industry has evolved rapidly over the last three years and we have been able to bring together an experienced team to serve patients across the whole spectrum of chronic illness in Australia. 

“From the patient’s perspective, the most important factors we are targeting is affordability, accessibility and providing care in the comfort of their own home. We are a patient led clinic proud to provide holistic care. We are extremely excited to expand our services across the country in partnership with Lyphe Group UK.

“We are big on personalised and friendly care as we want our patients to put a name to the face, which is especially important in a telehealth clinic. Our processes have been made to self-serve as much as possible, automating as much as we can in order to have more time to spend with our patients.” 

Jonathan Nadler, CEO of Lyphe Group UK added: “As a company we are committed to improving accessibility to patients, so I am delighted to see our services expand to Australia. I’m pleased that Lyphe Clinic has ensured that prices are attainable with the highest level of care, making services available to as many patients as possible, many of whom are on pension or disability support.

 “I look forward to seeing the expansion of access to medical cannabis for those that benefit from it.”

• Product Earth: UK expo to celebrate the cannabis plant
• LYPHE Group launches industry-first patient representative board
• Kanabo brings its unique VapePod to UK patients
• LYPHE Group imports flower-based cannabis products to UK
• Study highlights training gaps among US cannabis dispensaries